Generic Acomplia is available only to private patients with prescription, as the medication is currently awaiting authorization of the National Institute for Health and Clinical Excellence (NICE) who are expected to take a few years. If Generic Acomplia is authorised it is thought that obese patients, and over-weight patients considered to be at serious risk of type 2 diabetes or cardiovascular disease, may be offered the tablets.

Generic Rimonabant targets an area in the brain called the Endo-cannabinoid System. It blocks the receptors in this area, meaning that Cannabinoids (chemical compounds containing hunger messages) cannot reach the system. This lowers the intake of calories, causing weight control. The Endocannabinoid system affects the regulation of fat storage, the breaking down of sugars, fats and of the regulation of body weight and metabolism.

Whilst available in the EU since 2006 for use as an adjunct to diet and exercise for obese or over-weight patients with associated risk factors, Acomplia failed to gain FDA authorization in the US. Worries had been growing that patients taking Acomplia (or Zimulti as it was sold in the States) were at heightened risk of psychiatric adverse events, including suicidality.

The promising findings with Acomplia (rimonabant) have been confirmed in a series of laboratory tests, including pivotal phase III tests involving over 6,000 obese patients that were carried out in both the US and Europe. Two-year statistics from the phase III multicentre Generic Rimonabant In Obesity (RIO) tests, which compared rimonabant at doses of 5mg and 20mg with placebo with regard to weight loss and alleviation of weight gain, illustrated that the positive outcomes seen after a year’s use were held over thefull two-year test period.

You may use Generic Rimonabant as a supplement to diet and training to help you to lose of obese or over-weight, if you have Type 2 diabetes and heightened level of fat in the blood. Also the cardiovascular disease risk will be lessend. Generic Rimonabant is taken prior to food in the morning. The usual dose is 20mg, which must be ingested a glass of water.